128 related articles for article (PubMed ID: 11970731)
1. Derivatives of benzotetrazine-1,3-dioxide are new NO-donors, activators of soluble guanylate cyclase, and inhibitors of platelet aggregation.
Pyatakova NV; Khropov YV; Churakov AM; Tarasova NI; Serezhenkov VA; Vanin AF; Tartakovsky VA; Severina IS
Biochemistry (Mosc); 2002 Mar; 67(3):329-34. PubMed ID: 11970731
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
3. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
4. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide].
Belushkina NN; Grigor'ev NB; Severina IS
Biokhimiia; 1994 Nov; 59(11):1689-97. PubMed ID: 7873676
[TBL] [Abstract][Full Text] [Related]
7. Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2, 5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide: role of soluble guanylate cyclase, nitric oxide and thiols.
Kots AY; Grafov MA; Khropov YV; Betin VL; Belushkina NN; Busygina OG; Yazykova MY; Ovchinnikov IV; Kulikov AS; Makhova NN; Medvedeva NA; Bulargina TV; Severina IS
Br J Pharmacol; 2000 Mar; 129(6):1163-77. PubMed ID: 10725265
[TBL] [Abstract][Full Text] [Related]
8. [Soluble guanylate cyclase in the molecular mechanism underlying the therapeutic action of drugs].
Piatakova NV; Severina IS
Biomed Khim; 2012; 58(1):32-42. PubMed ID: 22642150
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of ADP-induced platelet aggregation by guanidine thiols--a novel class of guanylate cyclase activators and NO-synthase substrates].
Belushkina NN; Severina IS
Biokhimiia; 1996 Dec; 61(12):2140-6. PubMed ID: 9156556
[TBL] [Abstract][Full Text] [Related]
10. YC-1-like potentiation of NO-dependent activation of soluble guanylate cyclase by derivatives of protoporphyrin IX.
Severina IS; Pyatakova NV; Shchegolev AY; Ponomarev GV
Biochemistry (Mosc); 2006 Mar; 71(3):340-4. PubMed ID: 16545073
[TBL] [Abstract][Full Text] [Related]
11. The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide.
Roger S; Badier-Commander C; Paysant J; Cordi A; Verbeuren TJ; Félétou M
Br J Pharmacol; 2010 Nov; 161(5):1044-58. PubMed ID: 20977455
[TBL] [Abstract][Full Text] [Related]
12. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
[TBL] [Abstract][Full Text] [Related]
13. Nonselective inhibition of monoamine oxidases A and B by activators of soluble guanylate cyclase.
Severina IS; Axenova LN; Veselovsky AV; Pyatakova NV; Buneeva OA; Ivanov AS; Medvedev AE
Biochemistry (Mosc); 2003 Sep; 68(9):1048-54. PubMed ID: 14606950
[TBL] [Abstract][Full Text] [Related]
14. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
15. [Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin].
Shchegolev AIu; Sidorova TA; Severina IS
Biomed Khim; 2009; 55(3):331-7. PubMed ID: 19663005
[TBL] [Abstract][Full Text] [Related]
16. Effect of isatin on nitric oxide-stimulated soluble guanylate cyclase from human platelets.
Medvedev A; Bussygyna O; Pyatakova N; Glover V; Severina I
Biochem Pharmacol; 2002 Feb; 63(4):763-6. PubMed ID: 11992646
[TBL] [Abstract][Full Text] [Related]
17. Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase.
Severina IS; Bussygina OG; Pyatakova NV; Khropov YV; Krasnoperov RA
Eur J Pharmacol; 2000 Oct; 407(1-2):61-4. PubMed ID: 11050291
[TBL] [Abstract][Full Text] [Related]
18. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
[TBL] [Abstract][Full Text] [Related]
19. [The activation of soluble guanylate cyclase by new NO donors as the basis of a directed search for new efficacious vasodilators and antiaggregants].
Severina IS; Bussygina OG; Piatakova NV
Vestn Ross Akad Med Nauk; 2000; (4):25-30. PubMed ID: 10832410
[TBL] [Abstract][Full Text] [Related]
20. The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum.
Göçmen C; Büyüknacar HS; Kots AY; Murad F; Kiroglu O; Kumcu EK
J Pharmacol Exp Ther; 2006 Feb; 316(2):753-61. PubMed ID: 16254132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
